Company Overview
About Ceribell
Ceribell is a commercial-stage medical technology company that has reimagined the electroencephalogram (EEG) for the acute care setting. Its flagship product is a rapid-application, disposable EEG system with an AI algorithm called Clarity that detects electrographic seizures in real time. The platform is FDA-cleared for use across all patient ages — from pre-term neonates through adults — making it the only point-of-care EEG with that breadth of clearance. In December 2025, Ceribell received additional FDA 510(k) clearance for its AI-powered delirium monitoring solution, the first and only FDA-cleared delirium screening and monitoring device.
Business Model & Competitive Advantage
Ceribell went public on Nasdaq (CBLL) and reported full-year 2025 revenue of $89.1M, up 36% year-over-year, with Q4 2025 revenue of $24.8M (up 34% YoY). For 2026, the company guided to $111M–$115M in revenue, representing approximately 25–29% growth. In January 2026, the FDA granted Ceribell a Breakthrough Device Designation for an LVO (large vessel occlusion) stroke detection and monitoring solution, expanding its neurological monitoring pipeline beyond seizure detection into stroke and delirium.
Competitive Landscape 2025–2026
Ceribell''s competitive advantage lies in its rapid-application electrode array — which can be placed in under two minutes by bedside nursing staff — combined with its proprietary Clarity AI algorithm for continuous seizure probability scoring. The system is designed to capture nonconvulsive seizures that are invisible to standard clinical observation, a critical capability in ICUs and emergency departments where seizure burden is significantly underdiagnosed. The company''s longer-term strategy spans three horizons: penetrating seizure detection in acute care, expanding within acute care to delirium and stroke, and eventually extending into outpatient and broader neurological settings.
Key Differentiators
Market Leader
Ceribell is recognized as a market leader in the Healthcare sector, demonstrating strong industry presence and customer trust.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
athenahealth
athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on
Epic Systems
Epic Systems Corporation was founded in 1979 by Judith Faulkner and is headquartered in Verona, Wisconsin, remaining privately held with Faulkner as majority owner. The company develops large-scale el
Pfizer
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The compan
Moderna
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stép
Amgen
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologic
Veeva Systems
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv
Compare Ceribell with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Ceribell? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Ceribell Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Ceribell vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →